Protein Plus: Improving Infant Growth Through Diet and Enteric Health

• Status: Active, not recruiting
• Trial end date: 2020-11-30
• Target enrollment: 0
• Participant gender: All

Summary

This cluster-randomized controlled trial is designed to address linear growth faltering in 6-12-mo-old Bangladesh infants through a proof-of-concept package of interventions to a) increase intake of high quality protein and b) control enteric pathogens.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johns Hopkins Bloomberg School of Public Health
• Collaborators: Bill and Melinda Gates Foundation; International Centre for Diarrhoeal Disease Research, Bangladesh
• Treatments: Azithromycin

Criteria

Inclusion Criteria:

• Born to women enrolled in ongoing community trial (NCT02909179) over a one-year period

Exclusion Criteria:

• Born to women not registered as part of the ongoing community trial (NCT02909179)